Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
FI

Fumitaka Ito — 41 Patents

Pfizer: 34 patents #46 of 5,153Top 1%
NCNicca Chemical Co.: 2 patents #18 of 106Top 20%
University of California: 1 patents #8,022 of 18,278Top 45%
TKToshiba Kikai: 1 patents #381 of 713Top 55%
TCToshiba Machine Co.: 1 patents #70 of 186Top 40%
WCWarner-Lambert Company: 1 patents #930 of 1,610Top 60%
Overall (All Time): #75,001 of 4,157,543Top 2%
41 Patents All Time
Fumitaka Ito has been granted 41 US patents while listed as an inventor at Pfizer. The first was granted in 1987 and the most recent in June 2021. Fumitaka Ito ranks #75,001 of 4,157,543 US inventors in our database (top 1.8%). Patent records list Fumitaka Ito in Fukui, CT, JP.

Issued Patents All Time

Showing 1–25 of 41 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11034917 Hard surface detergent composition Junichi Nakajima, Masahiko SHIMAKAWA 2021-06-15
10280385 Detergent composition for hard surfaces Junichi Nakajima, Masahiko SHIMAKAWA 2019-05-07
6869960 N-substituted spiropiperidine compounds as ligands for ORL-1 receptor Hiroki Koike, Asato Morita 2005-03-22 $274,842,000
6861425 Benzimidazole compounds as ORL1-receptor agonists Hirohide Noguchi, Yoriko Ohashi, Hirohisa Shimokawa 2005-03-01 $134,880,000
6624313 Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists Keith M. DeVries, Michel A. Couturier, Brian M. Andresen, John Tucker 2003-09-23
6465478 1,3,8-Triuazaspiro(4,5)decanone compounds as ORL1-receptor agonists Yoriko Ohashi 2002-10-15 $179,452,000
6423725 4-(2-keto-1-benzimidazolinyl)piperidine compounds as ORL1-receptor agonists Hirohide Noguchi, Yoriko Ohashi, Hiroshi Kondo, Tatsuya Yamagishi 2002-07-23 $298,656,000
6340681 2-benzimidazolylamine compounds as ORL-1-receptor agonists 2002-01-22 $1,906,471,000
6313302 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists Hiroshi Kondo 2001-11-06 $456,904,000
6310061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists Hiroshi Kondo 2001-10-30 $781,495,000
6307061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists Hiroshi Kondo 2001-10-23 $486,737,000
6303602 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists Hiroshi Kondo 2001-10-16 $419,221,000
6294557 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists Hiroshi Kondo 2001-09-25 $489,072,000
6294569 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists Hiroshi Kondo 2001-09-25 $489,072,000
6222038 Quinuclidine derivatives Hiroshi Kondo, Masami Nakane, John A. Lowe, III, Terry J. Rosen, Kaoru Shimada 2001-04-24
6201007 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists Hiroshi Kondo 2001-03-13 $892,681,000
6172067 2-substituted-1-piperidyl benzimidazole compounds as ORL1-receptor agonists Hirohide Noguchi, Hiroshi Kondo 2001-01-09 $917,296,000
6110947 Pyrrolidinyl hydroxamic acid compounds and their production process 2000-08-29 $295,433,000
6027401 Headstock of a polishing machine Hideo Saito 2000-02-22
5984764 Method of dressing an abrasive cloth and apparatus therefor Hideo Saito, Hiromi Nishihara, Hironobu Hirata 1999-11-16
5952369 Pyrrolidinyl hydroxamic acid compounds and their production process 1999-09-14 $262,702,000
5939433 Quinuclidine derivatives Hiroshi Kondo, Masami Nakane, Kaoru Shimada, John A. Lowe, III, Terry J. Rosen 1999-08-17 $257,415,000
5886009 Quinuclidine derivative as a substance P antagonist Hiroshi Kondo, Masami Nakane, Kaoru Shimada 1999-03-23 $429,365,000
5859011 Dihydropyridine derivatives as bradykinin antagonist Hiroshi Kondo, David L. Hageman, John A. Lowe, III, Susumu Nakanishi, Fredric J. Vinick 1999-01-12 $376,393,000
5852038 Substituted 3-aminoquinuclidines Toshihide Kokura, Masami Nakane, Kunio Satake, Hiroaki Wakabayashi 1998-12-22 $228,111,000